Loading…
Zentalis Pharmaceuticals, Inc. is projected to rise to $7.41 by 2027, a +52% move from its current price of $4.88. ZNTL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $4.66 | $4.88 | $5.10 | -0.04% |
| Jul 15 | $4.58 | $4.88 | $5.19 | -0.09% |
| Jul 16 | $4.51 | $4.87 | $5.27 | -0.13% |
| Jul 17 | $4.45 | $4.87 | $5.33 | -0.17% |
| Jul 18 | $4.41 | $4.87 | $5.38 | -0.22% |
| Jul 19 | $4.36 | $4.87 | $5.43 | -0.26% |
| Jul 20 | $4.32 | $4.87 | $5.48 | -0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.32 | $4.87 | $5.48 | -0.30% |
| Week 2 | $4.10 | $4.85 | $5.74 | -0.60% |
| Week 3 | $3.94 | $4.84 | $5.94 | -0.90% |
| Week 4 | $3.80 | $4.82 | $6.11 | -1.20% |
| Week 5 | $3.69 | $4.81 | $6.26 | -1.50% |
| Week 6 | $3.58 | $4.79 | $6.41 | -1.80% |
| Week 7 | $3.49 | $4.78 | $6.54 | -2.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.
It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer.
It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.
ZNTL trades at $4.61, with a market capitalization of $328.17M, ranking 3247 by market cap.
The 30-day price range is $3.38 to $6.30.
The technical picture shows a BULLISH sentiment, with RSI14 at 70. The 50-day simple moving average is $3.94 and the 200-day simple moving average is $2.57. The current support level is $3.52 and the resistance level is $4.61.
Forecasted price paths indicate an upward trajectory in the coming years: 2026 avg $4.61; 2027 avg $7.08; 2028 avg $7.18; 2029 avg $6.99; 2030 avg $8.27; 2031 avg $7.53; 2032 avg $8.33; 2033 avg $12.04; 2034 avg $12.75; 2035 avg $13.89; 2040 avg $19.77; 2050 avg $31.28. ROI pct values by year are: 2026 0; 2027 53.6; 2028 55.8; 2029 51.7; 2030 79.5; 2031 63.3; 2032 80.7; 2033 161.2; 2034 176.6; 2035 201.3; 2040 328.8; 2050 578.5. The sentiment in the forecast is BULLISH.
A major floor 57.0% below — a decisive break under it would weaken the trend.
The nearest floor, 27.9% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key ZNTL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZNTL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.79 | Buy | $4.75 | Buy |
| MA 10 | $4.63 | Buy | $4.58 | Buy |
| MA 20 | $4.16 | Buy | $4.34 | Buy |
| MA 50 | $4.04 | Buy | $4.03 | Buy |
| MA 100 | $3.58 | Buy | $3.63 | Buy |
| MA 200 | $2.70 | Buy | $3.14 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.79 | Neutral |
| Stoch RSI (14) | 72.78 | Neutral |
| CCI (20) | 100.66 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 32.61 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.61 | Buy |
| Awesome (5,34) | 0.75 | Buy |
| Ultimate (7,14,28) | 57.85 | Neutral |
| Momentum (10) | 1.09 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 4.88 | Buy |
| ADX (14) | 17.46 | Neutral |
| ATR (14) | 0.18 | Info |
Sentiment: BULLISH. RSI(14): 70. The 50-day SMA is $3.94 and the 200-day SMA is $2.57. Support is at $3.52 and resistance at $4.61.
The 30-day range is $3.38 to $6.30.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.37 | $4.88 | $6.75 | 0% | Neutral | |
| $5.55 | $7.41 | $10.65 | +52% | Bullish | |
| $5.49 | $7.70 | $11.69 | +58% | Bullish | |
| $5.00 | $7.31 | $11.59 | +50% | Bullish | |
| $5.75 | $8.73 | $14.35 | +79% | Bullish | |
| $5.27 | $8.28 | $14.03 | +70% | Bullish | |
| $5.49 | $8.91 | $15.51 | +83% | Bullish | |
| $7.58 | $12.69 | $22.64 | +160% | Bullish | |
| $7.97 | $13.76 | $25.10 | +182% | Bullish | |
| $8.31 | $14.77 | $27.51 | +203% | Bullish | |
| $10.70 | $21.83 | $44.29 | +347% | Bullish | |
| $14.99 | $33.32 | $76.27 | +583% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.37 | $4.88 | $5.77 | +0.00% |
| August 2026 | $3.76 | $4.51 | $5.62 | -7.49% |
| September 2026 | $3.86 | $4.69 | $5.95 | +3.92% |
| October 2026 | $4.07 | $4.99 | $6.42 | +6.41% |
| November 2026 | $4.03 | $4.98 | $6.49 | -0.14% |
| December 2026 | $4.11 | $5.12 | $6.75 | +2.77% |
Click any year to see its month-by-month ZNTL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ZNTL could reach as high as $6.75, with a base case around $4.88 and support toward $1.37 — roughly 0% from $4.88. A consolidation phase looks the most probable path here.
Expect ZNTL to range from $5.55 to $10.65 through 2027. The $7.41 average target implies a +52% move from current prices. That is up +52% on the projected 2026 average. Momentum favours further upside here.
The ZNTL price prediction for 2028 points to an average of $7.70 (low $5.49, high $11.69) — a potential gain of +58% on today's $4.88. Buyers look set to stay in control over this stretch.
In 2029, ZNTL is projected to trade between $5.00 and $11.59, averaging $7.31 — a potential gain of +50% from today's $4.88. That is -5% versus the projected 2028 average. Momentum favours further upside here.
Zentalis Pharmaceuticals, Inc.'s 2030 outlook centres on $8.73, within a $5.75 to $14.35 range. That is up +19% on the projected 2029 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ZNTL could reach as high as $14.03, with a base case around $8.28 and support toward $5.27 — roughly +70% from $4.88. Momentum favours further upside here.
Expect ZNTL to range from $5.49 to $15.51 through 2032. The $8.91 average target implies a +83% move from current prices. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ZNTL price prediction for 2033 points to an average of $12.69 (low $7.58, high $22.64) — a potential gain of +160% on today's $4.88. Momentum favours further upside here.
In 2034, ZNTL is projected to trade between $7.97 and $25.10, averaging $13.76 — a potential gain of +182% from today's $4.88. That is up +8% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Zentalis Pharmaceuticals, Inc.'s 2035 outlook centres on $14.77, within a $8.31 to $27.51 range. That is up +7% on the projected 2034 average. That marks a +203% change versus current levels. Momentum favours further upside here.
By 2040, ZNTL could reach as high as $44.29, with a base case around $21.83 and support toward $10.70 — roughly +347% from $4.88. Buyers look set to stay in control over this stretch.
Expect ZNTL to range from $14.99 to $76.27 through 2050. The $33.32 average target implies a +583% move from current prices. That is up +53% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ZNTL today (≈ 204.918033 ZNTL) could be worth
$6,827.31
+$5,827.31 (+583%) by 2050 · US Dollar
Based on the average projected ZNTL price of $33.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZNTLwould be worth at today's price.
$1,000 invested in ZNTL on Jul 10, 2025 (≈ 729.927005 ZNTL) would be worth
$3,562.04
+$2,562.04 (+256.2%) today · 3.56× · US Dollar
Based on a ZNTL entry price of $1.37 vs. today's $4.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.46 | $1,094.17 | +9.4% |
| 1 month ago | $3.6 | $1,355.56 | +35.6% |
| 3 months ago | $6.61 | $738.28 | -26.2% |
| 6 months ago | $3.49 | $1,398.28 | +39.8% |
| 1 year ago | $1.37 | $3,562.04 | +256.2% |
| All time (5.0y) ago | $46.84 | $104.18 | -89.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZNTL forecast.
Our base-case forecast reaches $9.80 around 2033.
Implied market cap at $9.80: $697.63M
By 2030, the forecast shows avg price $8.27 with ROI 79.5 and bullish sentiment.
By 2040, the forecast shows avg price $19.77 with ROI 328.8 and bullish sentiment, and by 2050 the forecast shows avg price $31.28 with ROI 578.5 and bullish sentiment. These are projected price paths and ROIs for long-term planning; they reflect estimates of future performance and are not guarantees.
Overall, the multi-year outlook signals strong upside potential in later years, but actual results will depend on future market conditions and other factors beyond the provided figures.
Tap a question to reveal the answer.
Avg $8.27; min $5.35; max $13.83; ROI 79.5; sentiment BULLISH. These are estimates, not guaranteed.
Forecasts show bullish sentiment in years beyond 2026, with 2026 avg $4.61 and 2027 avg $7.08, rising toward $8.27 by 2030 and $31.28 by 2050; ROI values reach up to 578.5. These are estimates, not guaranteed.
Yes—the 2050 forecast shows avg $31.28, with max $71.94 and min $14.08; ROI 578.5. These are estimates, not guaranteed.
Current price $4.61; market cap $328.17M. Rank 3247 by market cap.
The 30-day range is $3.38 to $6.30.
Zentalis Pharmaceuticals, Inc. Community Discussion
0Share your Zentalis Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.